VERSANT VENTURES BACKS APREA AB CONTINUING GLOBAL INVESTMENT STRATEGY -- Tenth company sourced by firm’s European team in the past five years -- -- Developing first ever therapy targeting the tumor suppressing protein

First Page		Document Content
Date: 2016-03-09 17:09:48 HealthCap Versant Chemotherapy		VERSANT VENTURES BACKS APREA AB CONTINUING GLOBAL INVESTMENT STRATEGY -- Tenth company sourced by firm’s European team in the past five years -- -- Developing first ever therapy targeting the tumor suppressing protein Add to Reading List Source URL: www.versantventures.com Download Document from Source Website File Size: 46,51 KB Share Document on Facebook